In particular, ILC2s are mostly defined as a protumorigenic subset, given their type-2 immune functions through the secretion of IL-13, IL-5, IL-9, and the epidermal growth factor AREG, which has a detrimental role in various types of cancer [15–19]. This evidence concerns the gene IL13 and cancer.